To Evaluate the Delivery Timing Safety and Efficacy of AntiTachycardia Pacing (BIO|ATP)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 398 participants.
Also called NCT05426785
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 398 participants
- Registry
-
NCT05426785
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05426785. Randomized; no masking; primary purpose treatment. Start 2023-05-15 (actual); primary completion 2027-05-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Evaluate the Delivery Timing Safety and Efficacy of AntiTachycardia Pacing (BIO|ATP)
- Acronym
- BIO|ATP
- Condition
- Implantable Cardioverter Defibrillator(ICD)
- Intervention (Device)
- 1:1 ratio for Treatment Group and Control Group
- Lead sponsor
- Biotronik SE & Co. KG
- Collaborator
- Biotronik Japan, Inc.
Record details
- Record id
cardio:ct-nct05426785- Content hash
9ee18e53c39362ee988e16d78cb9a42b348bd5f82eb5bb7d1c5d6251de1e88d9